IP Library Granted Patent US 9,480,966
Granted Patent B2
US 9,480,966 · App. 14/261,900 · Granted Nov 1, 2016

Substrates and methods for collection, stabilization and elution of biomolecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,480,966
App. No.
14/261,900
Granted
Nov 1, 2016
Kind
B2
Abstract

A solid substrate for the extraction, stabilization, and storage of proteins is provided. The substrate includes: a polysaccharide, such as melezitose under a substantially dry state. The substrate is configured to extract proteins from a sample and stabilize the extracted proteins in a dry format under ambient conditions for a prolonged period of time. Methods for collecting and recovering the proteins stored in the dry solid substrate are also described.

Claims (18)

1. A method for extracting, stabilizing and eluting a protein or peptide from a biological sample disposed on a non-dissolvable dry solid substrate, wherein the non-dissolvable dry solid substrate comprises cellulose, cellulose acetate or glass fiber, or a combination thereof, and wherein the non-dissolvable dry solid substrate is a melezitose-impregnated solid substrate that is prepared by dipping the substrate in a melezitose solution having a melezitose concentration in a range of 10% to 30% on a weight per volume basis, the method comprising:

contacting the biological sample to the melezitose-impregnated solid substrate without solubilizing the melezitose-impregnated solid substrate;

drying the biological sample to a water content of less than 2%; and

eluting the a protein or peptide from the biological sample dried on the melezitose-impregnated solid substrate by rehydrating the melezitose-impregnated solid substrate in an elution buffer.

2. The method of claim 1 , wherein the melezitose-impregnated solid substrate provides 70 to 90% recovery of the protein or peptide from the substrate.

3. The method of claim 1 , wherein the melezitose-impregnated solid substrate elutes the protein or peptide in an intact form.

4. The method of claim 1 , wherein the melezitose-impregnated solid substrate comprises cellulose.

5. The method of claim 1 , wherein the melezitose-impregnated solid substrate is prepared by dipping the substrate in a melezitose solution having a melezitose concentration of 15% on a weight per volume basis.

6. The method of claim 1 , wherein the melezitose-impregnated solid substrate further comprises one or more lysis reagents, nucleic acid denaturing reagents and combinations thereof.

7. The method of claim 6 , wherein the lysis reagent is selected from thiocyanate salts, detergents, urea or combinations thereof.

8. The method of claim 6 , wherein the lysis reagent is selected from guanidinium thiocyanate, sodium thiocyanate, sodium dodecyl sulfate (SDS), arginine, urea or combinations thereof.

9. The method of claim 1 , wherein the melezitose-impregnated solid substrate further comprises a polysaccharide selected from dextran, ficoll, chitosan, amylopectin, alginate, carboxymethyl cellulose or combinations thereof.

10. The method of claim 9 , wherein the polysaccharide is ficoll.

11. The method of claim 9 , wherein the melezitose-impregnated solid substrate further comprises 1 to 10% ficoll.

12. The method of claim 1 , wherein the melezitose-impregnated solid substrate further comprises reducing agents, buffers, anti-oxidants, chelating agents or combinations thereof impregnated therein.

13. The method of claim 12 , wherein the reducing agent is selected from dithiothreitol (DTT), 2-mercaptoethanol (2-ME), tris(2-carboxyethyl)phosphine (TCEP) or combinations thereof.

14. The method of claim 12 , wherein the buffer is selected from 2-Amino-2-hydroxymethyl-propane-1,3-diol (Tris), 2-(N-morpholine) ethanesulfonic acid (MES), 3-(N-morpholino) propanesulfonic acid (MOPS), citrate buffers, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), phosphate buffers or combinations thereof.

15. The method of claim 12 , wherein the chelating agent is selected from ethylenediaminetetraacetic acid (EDTA), citric acid, ethylene glycol tetraacetic acid (EGTA), or combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 054300/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: GENERAL ELECTRIC COMPANY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 053981/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2014
From: KOVACS, ERNEST WILLIAM; KVAM, ERIK LEEMING; LI, BING; MONDELLO, FRANK JOHN
To: GENERAL ELECTRIC COMPANY
Reel/Frame 032760/0280 →